Arjun Law

1.8k total citations
142 papers, 1.0k citations indexed

About

Arjun Law is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Arjun Law has authored 142 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Hematology, 40 papers in Public Health, Environmental and Occupational Health and 31 papers in Oncology. Recurrent topics in Arjun Law's work include Hematopoietic Stem Cell Transplantation (80 papers), Acute Myeloid Leukemia Research (44 papers) and Acute Lymphoblastic Leukemia research (36 papers). Arjun Law is often cited by papers focused on Hematopoietic Stem Cell Transplantation (80 papers), Acute Myeloid Leukemia Research (44 papers) and Acute Lymphoblastic Leukemia research (36 papers). Arjun Law collaborates with scholars based in Canada, Sweden and India. Arjun Law's co-authors include Jeffrey H. Lipton, Rajat Kumar, Fotios V. Michelis, Auro Viswabandya, Wilson Lam, Dennis Dong Hwan Kim, Jonas Mattsson, María Queralt Salas, Brent A. Williams and Armand Keating and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Arjun Law

124 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arjun Law Canada	17	619	391	275	201	150	142	1.0k
Maija Itälä‐Remes Finland	17	680 1.1×	239 0.6×	229 0.8×	191 1.0×	214 1.4×	60	914
Federica Galaverna Italy	15	581 0.9×	333 0.9×	267 1.0×	151 0.8×	115 0.8×	48	867
Xavier Poiré Belgium	17	505 0.8×	401 1.0×	186 0.7×	184 0.9×	115 0.8×	69	971
Nelli Bejanyan United States	19	1.1k 1.8×	443 1.1×	414 1.5×	334 1.7×	232 1.5×	84	1.5k
Elizabeth Rich United States	17	681 1.1×	556 1.4×	451 1.6×	183 0.9×	196 1.3×	56	1.2k
Sam Penza United States	17	467 0.8×	321 0.8×	188 0.7×	134 0.7×	88 0.6×	63	806
Joachim Deeg United States	10	870 1.4×	224 0.6×	335 1.2×	141 0.7×	170 1.1×	17	1.0k
Xiaochun Zhu United States	12	509 0.8×	250 0.6×	371 1.3×	158 0.8×	101 0.7×	35	969
Karin Kolbe Germany	22	759 1.2×	465 1.2×	279 1.0×	202 1.0×	146 1.0×	53	1.2k
Seung‐Ah Yahng South Korea	18	752 1.2×	193 0.5×	280 1.0×	240 1.2×	181 1.2×	88	1.0k

Countries citing papers authored by Arjun Law

Since Specialization

Citations

This map shows the geographic impact of Arjun Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjun Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjun Law more than expected).

Fields of papers citing papers by Arjun Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjun Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjun Law. The network helps show where Arjun Law may publish in the future.

Co-authorship network of co-authors of Arjun Law

This figure shows the co-authorship network connecting the top 25 collaborators of Arjun Law. A scholar is included among the top collaborators of Arjun Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjun Law. Arjun Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Jongbok, Hyeonjeong Kang, Branson Chen, et al.. (2025). Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD. Journal of Experimental & Clinical Cancer Research. 44(1). 28–28. 1 indexed citations

Jamani, Kareem, Mohamed Elemary, Ivan Pašić, et al.. (2025). Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival. Annals of Hematology. 104(10). 5403–5413.

Chen, Carol, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms. European Journal Of Haematology. 115(2). 142–152. 3 indexed citations

Chen, Carol, Eshetu G. Atenafu, Arjun Law, et al.. (2025). Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure. Transplantation and Cellular Therapy. 31(10). 810–819. 1 indexed citations

Remberger, Mats, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia. Transplantation and Cellular Therapy. 31(11). 916.e1–916.e11. 1 indexed citations

Remberger, Mats, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation. Cancers. 17(4). 651–651.

Law, Arjun, Wilson Lam, Mats Remberger, et al.. (2025). Impact of graft‐versus‐host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. 207(3). 938–945. 1 indexed citations

Law, Arjun, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). A decade of experience using ATG and PTCy for graft‐versus‐host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation. British Journal of Haematology. 207(5). 2049–2058.

Subramanian, Aravind, et al.. (2024). Differential Impact of CD34+ Cell Dose for Different Age Groups in Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia: A Machine Learning-Based Discovery. Transplantation and Cellular Therapy. 30(2). S105–S105.

10.

Pašić, Ivan, Mats Remberger, Carol Chen, et al.. (2024). Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study. Transplantation and Cellular Therapy. 30(7). 681.e1–681.e11. 2 indexed citations

11.

Subramanian, Aravind, et al.. (2024). Differential impact of CD34+ cell dose for different age groups in allogeneic hematopoietic cell transplantation for acute leukemia: a machine learning–based discovery. Experimental Hematology. 141. 104684–104684.

12.

Remberger, Mats, Carol Chen, Igor Novitzky‐Basso, et al.. (2024). PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation. Blood Advances. 9(3). 660–669. 7 indexed citations

13.

Pašić, Ivan, Arjun Law, Wilson Lam, et al.. (2024). Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience. European Journal Of Haematology. 113(4). 477–484. 3 indexed citations

14.

Novitzky‐Basso, Igor, Ivan Pašić, Wilson Lam, et al.. (2023). A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes. Hematology/Oncology and Stem Cell Therapy. 17(1). 60–71. 2 indexed citations

15.

Lee, Katherine J., Shiyi Chen, Arjun Law, et al.. (2021). Weight Loss after Allogeneic Stem Cell Transplantation Is Associated with Increased Mortality. Transplantation and Cellular Therapy. 27(3). S181–S182. 1 indexed citations

16.

Lipton, Jeffrey H., Dennis Dong Hwan Kim, Auro Viswabandya, et al.. (2021). Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients. Clinical Lymphoma Myeloma & Leukemia. 22(5). e327–e334. 4 indexed citations

17.

Pašić, Ivan, Jeffrey H. Lipton, Dennis Dong Hwan Kim, et al.. (2020). Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation. Annals of Hematology. 99(6). 1377–1387. 14 indexed citations

18.

Salas, María Queralt, Eshetu G. Atenafu, Wilson Lam, et al.. (2020). High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications. PubMed. 3(3). 48–58. 1 indexed citations

19.

Chhabra, Puneet, et al.. (2012). Methotrexate induced lung injury in a patient with primary CNS lymphoma: A case report. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012020–e2012020. 11 indexed citations

20.

Lam, Fred C., Arjun Law, & William Wykes. (2009). Herpes zoster ophthalmicus. BMJ. 339(aug13 1). b2624–b2624. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact